These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 21854760)

  • 1. Transcriptional activity of DNMT3B in pancreatic cancer cells: effects of -149 (C→T) promoter polymorphism.
    Xiao Y; Word B; Hammons G; Lyn-Cook B
    Biochem Biophys Res Commun; 2011 Nov; 415(2):220-3. PubMed ID: 21854760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNMT3B polymorphisms and risk of primary lung cancer.
    Lee SJ; Jeon HS; Jang JS; Park SH; Lee GY; Lee BH; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Cho YL; Jung TH; Park JY
    Carcinogenesis; 2005 Feb; 26(2):403-9. PubMed ID: 15528220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers.
    Jin F; Dowdy SC; Xiong Y; Eberhardt NL; Podratz KC; Jiang SW
    Gynecol Oncol; 2005 Feb; 96(2):531-8. PubMed ID: 15661247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta DNMT3B variants regulate DNA methylation in a promoter-specific manner.
    Wang J; Bhutani M; Pathak AK; Lang W; Ren H; Jelinek J; He R; Shen L; Issa JP; Mao L
    Cancer Res; 2007 Nov; 67(22):10647-52. PubMed ID: 18006804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population.
    Aung PP; Matsumura S; Kuraoka K; Kunimitsu K; Yoshida K; Matsusaki K; Nakayama H; Yasui W
    Oncol Rep; 2005 Nov; 14(5):1151-4. PubMed ID: 16211278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased CXCR4 expression in AsPC1 pancreatic carcinoma cells with RNA interference-mediated knockdown of DNMT1 and DNMT3B.
    Przybylski M; Kozłowska A; Pietkiewicz PP; Lutkowska A; Lianeri M; Jagodzinski PP
    Biomed Pharmacother; 2010 Apr; 64(4):254-8. PubMed ID: 19932585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population.
    Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; El Kihal L; Hassar M; Akil A; Pineau P; Benjelloun S
    Infect Genet Evol; 2009 Sep; 9(5):877-81. PubMed ID: 19465161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression and promoter polymorphisms of DNA methyltransferase 3B in nasopharyngeal carcinomas in Taiwanese people: a case-control study.
    Chang KP; Hao SP; Tsang NM; Chang YL; Cheng MH; Liu CT; Lee YS; Tsai CL; Lee TJ; Wang TH; Tsai CN
    Oncol Rep; 2008 Jan; 19(1):217-22. PubMed ID: 18097598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer.
    Shen H; Wang L; Spitz MR; Hong WK; Mao L; Wei Q
    Cancer Res; 2002 Sep; 62(17):4992-5. PubMed ID: 12208751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of DNA methyltransferase 3b on FHIT expression and DNA methylation of the FHIT promoter region in hepatoma SMMC-7721 cells.
    Wang JX; Zhang YG; Zhao LS
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):273-7. PubMed ID: 19502167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset.
    Jones JS; Amos CI; Pande M; Gu X; Chen J; Campos IM; Wei Q; Rodriguez-Bigas M; Lynch PM; Frazier ML
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):886-91. PubMed ID: 16702365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference-mediated knockdown of DNMT1 and DNMT3B induces CXCL12 expression in MCF-7 breast cancer and AsPC1 pancreatic carcinoma cell lines.
    Sowińska A; Jagodzinski PP
    Cancer Lett; 2007 Sep; 255(1):153-9. PubMed ID: 17532557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antisense DNMT3b gene eukaryotic expression plasmid on expression of the DNMT3b gene in human biliary tract carcinoma cells.
    Zuo S; Dong JQ; Guo W; Liu MF; Xu LN; Luo J; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):123-8. PubMed ID: 16481298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel DNMT3B subfamily, DeltaDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer.
    Wang L; Wang J; Sun S; Rodriguez M; Yue P; Jang SJ; Mao L
    Int J Oncol; 2006 Jul; 29(1):201-7. PubMed ID: 16773201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of CXCR4 expression by tamoxifen is associated with DNA methyltransferase 3B up-regulation in MCF-7 breast cancer cells.
    Kubarek Ł; Kozłowska A; Przybylski M; Lianeri M; Jagodzinski PP
    Biomed Pharmacother; 2009 Sep; 63(8):586-91. PubMed ID: 19019622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of DNA methylation activity through Dnmt3L promoter methylation by Dnmt3 enzymes in embryonic development.
    Hu YG; Hirasawa R; Hu JL; Hata K; Li CL; Jin Y; Chen T; Li E; Rigolet M; Viegas-Péquignot E; Sasaki H; Xu GL
    Hum Mol Genet; 2008 Sep; 17(17):2654-64. PubMed ID: 18544626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis.
    Foltz G; Yoon JG; Lee H; Ryken TC; Sibenaller Z; Ehrich M; Hood L; Madan A
    Oncogene; 2009 Jul; 28(29):2667-77. PubMed ID: 19465937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation.
    Chang HC; Cho CY; Hung WC
    Cancer Res; 2006 Sep; 66(17):8413-20. PubMed ID: 16951151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer.
    Huidobro C; Urdinguio RG; Rodríguez RM; Mangas C; Calvanese V; Martínez-Camblor P; Ferrero C; Parra-Blanco A; Rodrigo L; Obaya AJ; Suárez-Fernández L; Astudillo A; Hernando H; Ballestar E; Fernández AF; Fraga MF
    Eur J Cancer; 2012 Sep; 48(14):2270-81. PubMed ID: 22244828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNMT3B promoter polymorphisms and maternal risk of birth of a child with Down syndrome.
    Coppedè F; Bosco P; Tannorella P; Romano C; Antonucci I; Stuppia L; Romano C; Migliore L
    Hum Reprod; 2013 Feb; 28(2):545-50. PubMed ID: 23081874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.